uric acid has been researched along with erlotinib hydrochloride in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bilici, A; Dagel, T; Dilege, S; Ertuglu, LA; Erus, S; Kanbay, M; Kapdağlı, M; Mandel, NM; Ozdogan, E; Selcukbiricik, F; Tanju, S; Tural, D | 1 |
1 other study(ies) available for uric acid and erlotinib hydrochloride
Article | Year |
---|---|
Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancer.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Protein Kinase Inhibitors; Retrospective Studies; Treatment Outcome; Uric Acid | 2020 |